ReviewFrontiers in oncology2024

Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects.

Charles J Milrod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.